TPD52: A NOVEL VACINE TARGET FOR PROSTATE CANCER

$511,235FY2008Department of DefenseDOD

Texas Tech University Health Sciences Center

Investigators

View source on USAspending →

TPD52: A NOVEL VACINE TARGET FOR PROSTATE CANCER · GrantIndex